CEFUROXIME AXETIL tablet

Страна: США

мова: англійська

Джерело: NLM (National Library of Medicine)

Активний інгредієнт:

CEFUROXIME AXETIL (UNII: Z49QDT0J8Z) (CEFUROXIME - UNII:O1R9FJ93ED)

Доступна з:

Golden State Medical Supply, Inc.

ІПН (Міжнародна Ім'я):

CEFUROXIME AXETIL

Склад:

CEFUROXIME 250 mg

Адміністрація маршрут:

ORAL

Тип рецепту:

PRESCRIPTION DRUG

Терапевтичні свідчення:

Cefuroxime axetil tablets are indicated for the treatment of adult patients and pediatric patients (13 years and older) with mild-to-moderate pharyngitis/tonsillitis caused by susceptible strains of Streptococcus pyogenes. Limitations of Use - The efficacy of cefuroxime axetil in the prevention of rheumatic fever was not established in clinical trials. - The efficacy of cefuroxime axetil in the treatment of penicillin-resistant strains of Streptococcus pyogenes has not been demonstrated in clinical trials. Cefuroxime axetil tablets are indicated for the treatment of pediatric patients (who can swallow tablets whole) with acute bacterial otitis media caused by susceptible strains of Streptococcus pneumoniae , Haemophilus influenzae (including β-lactamase–producing strains), Moraxella catarrhalis (including β-lactamase–producing strains), or Streptococcus pyogenes . Cefuroxime axetil tablets are indica

Огляд продуктів:

Cefuroxime axetil tablets USP, 250 mg of cefuroxime (as cefuroxime axetil), are white to off-white, capsule-shaped, film-coated tablets with "LUPIN" debossed on one side and "302" on the other side, supplied in bottles of 20 and 60. 20s Bottle NDC 60429-656-20 60s Bottle NDC 60429-656-60 Cefuroxime axetil tablets USP, 500 mg of cefuroxime (as cefuroxime axetil), are white to off-white, capsule-shaped, film-coated tablets with "LUPIN" debossed on one side and "303" on the other side, supplied in bottles of 20 and 60. 20s Bottle NDC 60429-657-20 60s Bottle NDC 60429-657-60 Store the tablets at 20 to 25°C (68 to 77°F) [See USP Controlled Room Temperature]. Replace cap securely after each opening.

Статус Авторизація:

Abbreviated New Drug Application

Характеристики продукта

CEFUROXIME AXETIL- CEFUROXIME AXETIL TABLET
GOLDEN STATE MEDICAL SUPPLY, INC.
----------
HIGHLIGHTS OF PRESCRIBING INFORMATION
CEFUROXIME AXETIL TABLETS
THESE HIGHLIGHTS DO NOT INCLUDE ALL THE INFORMATION NEEDED TO USE
CEFUROXIME AXETIL
TABLETS SAFELY AND EFFECTIVELY. SEE FULL PRESCRIBING INFORMATION FOR
CEFUROXIME AXETIL
TABLETS.
CEFUROXIME AXETIL TABLETS, FOR ORAL USE
INITIAL U.S. APPROVAL: 1987
INDICATIONS AND USAGE
Cefuroxime axetil tablets are a cephalosporin antibacterial drug
indicated for the treatment of the following
infections due to susceptible bacteria: ( 1)
Pharyngitis/tonsillitis (adults and pediatric patients) ( 1.1)
Acute bacterial otitis media (pediatric patients) ( 1.2)
Acute bacterial maxillary sinusitis (adults and pediatric patients) (
1.3)
Acute bacterial exacerbations of chronic bronchitis (adults and
pediatric patients 13 years and older) (
1.4)
Uncomplicated skin and skin-structure infections (adults and pediatric
patients 13 years and older) (
1.5)
Uncomplicated urinary tract infections (adults and pediatric patients
13 years and older) ( 1.6)
Uncomplicated gonorrhea (adults and pediatric patients 13 years and
older) ( 1.7)
Early Lyme disease (adults and pediatric patients 13 years and older)
( 1.8)
To reduce the development of drug-resistant bacteria and maintain the
effectiveness of cefuroxime axetil
tablets and other antibacterial drugs, cefuroxime axetil tablets
should be used only to treat or prevent
infections that are proven or strongly suspected to be caused by
bacteria.
DOSAGE AND ADMINISTRATION
Tablets and oral suspension are not bioequivalent and are therefore
not substitutable on a milligram-
per-milligram basis. ( 2.1)
Administer tablets with or without food. ( 2.2)
Administer cefuroxime axetil tablets as described in the dosage
guidelines. ( 2.2)
Dosage adjustment is required for patients with impaired renal
function. ( 2.5)
ADULT PATIENTS AND PEDIATRIC PATIENTS DOSAGE GUIDELINES FOR CEFUROXIME
AXETIL TABLETS
INFECTION
DOSAGE
DURATION (DAYS)
ADULTS AND ADOLESCENTS (13 YEAR